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Abstract.  Budding cells of the yeast Saccharomyces 
cerevisiae  possess a ring of 10-nm-diameter filaments, 
of unknown biochemical nature, that lies just inside 
the plasma membrane in the neck connecting the 
mother cell to its bud.  Electron microscopic observa- 
tions suggest that these filaments assemble at the bud- 
ding site coincident with bud emergence and disassem- 
ble shortly before cytokinesis (Byers, B. and L. 
Goetsch.  1976. J.  Cell Biol.  69:717-721).  Mutants 
defective in any of four genes (CDC3, CDCIO, CDC11, 
or CDC12)  lack these filaments and display a 
pleiotropic phenotype that involves abnormal bud 
growth and an inability to complete cytokinesis. We 
showed previously by immunofluorescence that the 
CDC12 gene product is probably a constituent of the 
ring of 10-nm filaments (Haarer,  B. and J.  Pringle. 
1987. Mol.  Cell.  BioL  7:3678-3687).  We now report 
the use of fusion proteins to generate polyclonal anti- 
bodies specific for the CDC3 gene product.  In im- 
munofluorescence experiments,  these antibodies deco- 
rated the neck regions of wild-type and mutant cells in 
patterns suggesting that the CDC3 gene product is also 
a constituent of the ring of 10-nm filaments. We also 
used the CDC3-specific  and CDC12-specific  antibodies 
to investigate the timing of localization of these pro- 
teins to the budding site. The results suggest that the 
CDC3 protein is organized into a ring at the budding 
site well before bud emergence and remains so orga- 
nized for some time after cytokinesis. The CDC12 
product appears to behave similarly, but may arrive at 
the budding site closer to the time of bud emergence, 
and disappear from that site more quickly after cytoki- 
nesis, than does the CDC3 product.  Examination of 
mating cells and cells responding to purified mating 
pheromone revealed novel arrangements  of the CDC3 
and CDC12 products in the regions of cell wall reor- 
ganization.  Both proteins were present in normal- 
looking ring structures at the bases of the first zygotic 
buds. 
T 
HE cell  cycle of the yeast Saccharomyces cerevisiae 
involves  a  series of morphogenetic events  including 
highly localized changes in the cell surface (7, 34, 40). 
As in other eukaryotes, elements of the cytoskeleton are be- 
lieved to play key roles in these morphogenetic events. In ad- 
dition to microtubules (2, 4, 18, 19, 21) and actin-containing 
structures (2, 21, 30), yeast cells contain another cytoskele- 
tal element, of uncertain biochemical nature, that may be in- 
volved in morphogenesis. This is a highly ordered array of 
filaments,  •10  nm in diameter,  that lies immediately subja- 
cent to the cellular membrane in the region of the mother- 
bud neck (4, 5). By EM, these filaments seem to appear at 
the onset of bud emergence and to disappear just before 
cytokinesis.  Temperature-sensitive  mutants defective in any 
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of four different genes (  CDC3, CDCIO, CDCll, and CDC12) 
lack these filaments  and  display  a  pleiotropic phenotype 
when  shifted  to  restrictive  temperature  (Byers,  B.,  and 
L. Goetsch. 1976. J.  Cell Biol. 70:35a;  1, 2,  10, 13, 33; B. 
Byers and L. Goetsch, personal communication).  The mu- 
tants  are  defective  in  cytokinesis,  yet continue  budding, 
DNA synthesis, and nuclear division, resulting in the forma- 
tion of multibudded,  multinucleate  cells.  In addition,  the 
mutants fail to localize chitin properly to the bases of buds 
formed at restrictive  temperature  (1), and these buds are 
grossly elongated  in comparison with normal buds (2,  13). 
Recently, we localized the CDC12 gene product to the vi- 
cinity  of the  10-nm  filaments  using  immunofluorescence 
with antibodies raised  against  fusion gene products  (10). 
This observation together with the disappearance of the illa- 
ments in cdcl2 mutants suggests that the CDC12 product is 
a constituent of the filaments. We now report the preparation 
of antibodies specific for the CDC3 gene product and their 
use to localize this product in a pattern quite similar to that 
© The Rockefeller University Press, 0021-9525/91/02/535/10  $2.00 
The Journal of Cell Biology, Volume 112, Number 4, February 1991 535-544  535 of the CDC12 product. In addition, we have used the CDC3- 
specific  and  CDC12-specific antibodies  to  investigate  the 
timing  of filament  assembly  and  disassembly  relative  to 
other landmark events at the beginning  and end of the cell 
cycle. We have also used the antibodies to ask whether struc- 
tures similar to the filament ring of budding cells appear dur- 
ing the morphogenetic response to mating pheromone (9, 26, 
36, 41, 42), during zygote formation (28, 41, 43), and during 
formation of the first zygotic bud. 
Materials and Methods 
Reagents 
Isopropyl/~-D-thingalactopyranoside, Ficoll (type 400),  and alpha factor 
were obtained from Sigma Chemical Co.  (St.  Louis, MO).  Rhodamine- 
conjugated goat anti-rat IgG (IgG fraction) was obtained from United States 
Biochemical Corporation (Cleveland, OH), and rat monoclonai anti-yeast- 
tubulin antibody (YOL1/34)  was provided by J.  Kilmartin (22).  Other re- 
agents were as described previously (10). 
Genetic and Recombinant-DNA Manipulations 
Standard procedures were used for recombinant-DNA manipulations (27), 
E. coli and yeast transformations (17, 27), and yeast genetic manipulations 
(37). 
Plasmids, Strains, and Growth Conditions 
Plasmid pUR290 (35) and E. coli strain BMH 71-18 (29) were provided by 
R.  Schekman and were handled essentially as described previously (35). 
Plasmid pATH2 was provided by T.  Koerner and A.  Tzagoloff and was 
propagated in E. coli strain I-IBI01 (27) essentially as described previously 
(10).  Other plasmids are described in reference 25 or in Results. 
The yeast strains used are listed in Table I. Except as noted, these were 
grown with rotary shaking in the rich, glucose-containing medium YM-P 
(24) at "023"C. Strain TD4 was pmpegated  in the appropriate selective min- 
imal media (10) either without plasmid or after transformation with appro- 
priate plasmids. Temperature-sensitive cell-division-cycle mutant strains 
were grown to 'o107 cells/ml at "023"C, then shifted to 36"C either without 
dilution or by diluting sixfold with fresh, prewarrned medium. 
Alpha-Factor  Arrest, Mating, and Synchronization 
To arrest cell proliferation with alpha factor, strain CP1AB-1AA was grown 
to "0107 cells/ml, then diluted in fresh medium to a density of 2  ×  106 
cells/ml. Alpha factor was then added (from a  1-mg/ml stock in water) to 
a final concentration of 5 #g/ml and incubation was continued. For mating 
experiments, strains C276-4A and C276-4B were grown to "0107 cells/mi. 
Equal numbers of cells of opposite mating types were mixed and collected 
on 0.45-#m filters to yield 4  x  10  ~ to 4  x  107 cells per 2.5-cm diameter 
filter. The filters were placed on YEPD plates and cells were collected after 
various periods of incubation by washing a filter with two 5-ml changes of 
phosphate buffer and adding formaldehyde to a final concentration of 3.7 %. 
Alternatively, the haploid strains were grown to "00.5  ×  107 cells/ml, cul- 
tures were mixed so as to provide equal numbers of cells of each mating 
type, and incubation was continued with slow rotary shaking. 
Two methods were used to obtain partially synchronized populations of 
budding cells. In the first, strain C276 cells were grown to early stationary 
phase and small cells were isolated using a Ficoll (mol wt 400,000) step- 
density gradient. 2 mi of culture were layered on a gradient of 4, 5, 6, and 
7% Ficoll in sterile water (32 mi in a 50-ml centrifuge tube) and spun in 
a Sorvall GLC-2B tabletop centrifuge for 5 rain at 800 rpm at "023"C. Ap- 
proximately 3 ml from the top of the gradient were removed and the cells 
in this fraction were harvested by spinning for 10 min at 1,500 rpm. These 
cells  were  predominantly  unbudded  and  bud  scar  free  (as judged  by 
Caicofluor staining; 10, 40). The cells were washed with 10 mi of YM-P 
medium to remove the remaining Ficoll and were then resuspended and in- 
cubated in 10 ml of fresh medium. In the second method, cells exposed to 
alpha factor for 160 rain as described above were harvested by centrifuga- 
tion at "023"C, then resuspended and incubated in an equal volume of fresh 
medium. 
Preparation of  Antigens and Antibodies 
The lacZ:CDC3  fusion protein was prepared from strain BMH 71-18 hat- 
Table L Saccharomyces  cerevisiae Strains Used  in this Study 
Strain  Relevant genotype  Source/reference 
C276  MATa/MAT~  (Ts  +, prototrophic)  44 
C276-4A  MATa  (Ts  +, prototrophic)  44 
C276-4B  MATa (Ts  +, prototrophic)  44 
CP1AB-1AA  MATa/MATa (diploid)  31 
TD4  MATa ura3-52 his4-519 1eu2-3,112 trpl-289  G.  Fink 
LH104-HO1  MATa/MATa cdc3-1/cdc3-1  2 
LH17012-HO1  MATa/MAToL  cdclO-l/cdclO-1  2 
JPT194-HO1  MATa/MAT~ cdc11-6/cdc11-6  2 
JPTA1493-HOI  MATa/MAT~ cdcl2-6/cdcl2-6  2 
314D5  MATa/MAT~ cdc4-1/cdc4-1  12 
473D3  MATa/MATa cdcS-1/cdcS-1  L.  Hartwell (14) 
JPT176-HO1  MATa/MATc~ cdcS-2/cdcS-2  This study* 
428D1  MATa/MATel cdc13-1/cdc13-1  8 
71M1-HO1  MATa/MATot cdc14-1/cdc14-1  This study~ 
JPT143-HO1  MATa/MAT~ cdc14-14/cdc14-14  This study* 
17017  MATa cdc15-1  14 
JPT161-HO1  MATa/MATc~ cdc15-28/cdc15-28  This study* 
281D5  MATa/MATc~ cdc16-1/cdc16-1  L.  Hartwell (14) 
H178-1-1  MATa cdc17-1  L.  Hartwell (14) 
14028-HO1  MATa/MATc~ cdc18-1/cdc18-1  This study§ 
* Mutants JPT176,  JPT143,  and JPT161  were isolated from strain C276-4A,  characterized,  and backcrossed essentially as described previously  (2) by A. E. M. 
Adams (1). Complementation and linkage analyses showed that these strains carried mutations in genes CDCS, CDC14, and CDC15, respectively (1; B. K. Haarer, 
unpublished  results);  allele numbers were assigned to avoid overlap with those assigned previously (14, 20). JPTI76-HO1  is the product of mating MATa and 
MATot segregants from the third backcross. JPTI43-HO1 is the product of mating JPT143 to a MATa segregant from the first backcross. JPT161-HO1  is the product 
of mating MATa and MATc~ segregants  from the first backcross. 
~: Strain 7041 (14) was crossed to C276-4B;  MATa and MAT~ segregants  were then mated to produce 7041-HO1. 
§ Strain  14028 (14) was mated to its MATc~ derivative H149-1-3  (obtained  from L. Hartwell)  to produce 14028-HO1. 
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containin~  plasmid  inserts 
and of IacZ :  CDC3 and trpE : 
CDC3 gene-fusion plasmids. 
(A) A  6.7-kbp Barn  HI frag- 
ment was subcloned from  plas- 
mid  YEpI3(CDC3)I  (refer- 
ence  25)  into  the  pBR322- 
derived  Barn  HI  site  of the 
yeast-E,  coli shuttle  vector 
YEpI02 to produce the cdc3- 
complementing plasmid YEpI02(CDC3)2 (reference  25).  (B) A 
2.4-kbp Pvu H-Sea I fragment was subcluned from YEpl 3(CDC3)1 
into the pBR322-derived  Pvu H site of  YEpl02 to produce the cdc3- 
complementing plasmid YEp-3PS1 (reference 25). (C)The 1.3-kbp 
Pvu H-Hind HI fragment from YEp-3PS1 was inserted  into the fu- 
sion vectors pUR290 and pATH2 to produce plasmids  pUR-PH1 
and pATH-PH8,  respectively.  In each case, the vector was linear- 
ized with Barn HI, treated with the Klenow fragment of DNA poly- 
merase to produce blunt ends,  digested with Hind HI, and then 
ligated to the gel-purified  Pvu H-Hind III frngment.  Thick arrows 
represent  the CDC3 coding region as inferred from DNA sequence 
analysis  (11), and stippled  boxes  represent adjacent yeast DNA. 
Open boxes represent  the/acZ and trpE coding regions and thin 
lines represent  other E. coli DNA. Thin arrows indicate the direc- 
tions of  transcription for the fusion genes. Restriction  sites are indi- 
cated: (B), Bam HI; H, Hind HI; P, Pvu II; Sc, Sca I; (B/P), Bam 
HI-Pvu H junction. 
(ref 25; Fig. 1 B). Although this plasmid retains cdc3-com- 
plementing activity, sequence analysis suggests that it does 
not contain the entire CDC3 co~g  region (11, 25; Fig. 1, A 
and B; and see below). To create a IacZ:CDC3 fusion gene, 
the 1.3-kbp Pvu II Hind HI fragment from YEp-3PS1 was in- 
serted into plasmid pUR290 (35) to produce plasmid pUR- 
PH1 as shown in Fig.  1 C. Analysis of the CDC3 sequence 
01) indicated that this arrangement v,  vuld result in an in- 
frame fusion of  the/acZ and CDC3 genes. Indeed, pUR-PH1 
directed the synthesis ofa ,,ol60-kD fusion protein (Fig. 2 A, 
lanes  1-3) when propagated under inducing conditions.  A 
trpE:CDC3  fusion  gene  was  constructed by inserting  the 
same Pvu H-Hind HI fragment into plasmid pATH2 to pro- 
duce plasmid pATH-PH8 as shown in Fig. 1 C. This plasmid 
boring fusion plasmid pUR-PH1 (see Results). Cells were grown  overnight 
in LB medium  plus ampicillin (50/tg/ml) at 37°C, then diluted 1:10  in the 
same medium  and grown 1 h at 37°C. Isopropyl  ~-v-thiogalactopyranoside 
(25 mg/rul in H20) was added to a final concentration  of ~/tg/ml, and 
cultures were  grown  for two more hours at 37°C. Cells were  then harvested, 
resuspended in loading buffer (10), and placed in a boiling water bath for 
1 to 2 min before loading samples on a pulyacrylamide gel (10). The 
trp  E: CDC3  fusion  protein was prepared  from E. coil  swain  HB101 contain- 
ing plasmid pATH-PH8 (see Results). Induction  of the fusion protein and 
isolation of  an insoluble protein fraction  were  essentially  as described  previ- 
ously (10) for the trpE:CDC12 fusion proteins. For immunization, both 
CDC3 fusion  proteins were purified from polyacrylamide  gel slices and in- 
jected separately into rabbits as described previously (10). 
CDC3-specific antibodies were affinity purified  from  crude anti- 
trpE:CDC3 antiserum using the IacZ:CDC3 fusion protein blotted to 
nitrocellulose as described previously  (10, 23). In the same manner, CDC3- 
specific antibodies were purified from crude anti-lacZ:CDC3 antiserum 
using nitrocellulose-bound trpE: CDC3 fusion  protein. CDC12-specific an- 
tibodies were prepared as described previously (10). 
Indirect Immunofluorescence and Other Methods 
Cells were ordinarily fixed by the addition of 37 % formaldehyde  directly 
to the culture medium (to a final concentration  of 3.7%), then examined  by 
phase-contrast microscopy (32) or washed and prepared for indirect im- 
munofluorescence  as described  previously  (2, 10, 21). Doubie-label experi- 
ments used FITC-conjugated  goat anti-rabbit IgG to visualize rabbit anti- 
CDC3 or anti-CDCl2 antibodies, plus rhodamine-conjugeted  goat anti-rat 
IgG to visualize rat antitubulin antibodies. Chitin rings were visualized by 
staining with Calcofluor  as described previously (10, 40). Other methods 
were as described previously (10, 32). 
Results 
Construction of lacZ  :  C DC  3 and trp  E :  C DC  3 
Gene Fusions 
From the CDC3-contairtng plasmid YEpl3(CDC3)I, a 2.4- 
kbp Pvu II-Sca I fragment was subeloned into the yeast-E. 
coli  shuttle  vector  YEpl02  to  create  plasmid  YEp-3PS1 
Figure 2, (A ) Identification  of lacZ:  CDC3 and trpE:CDC3 fusion 
proteins  by SDS-PAGE. (lanes  1-3) Total proteins  prepared from 
E. coli strain BMH 71-18 containing (Lane 1) no plasmid; (lane 2) 
plasmid pUR290; or (lane 3) plasmid pUR-PH1. (Lanes 4-6) Total 
proteins prepared from E. coli strain HB101 containing (lane 4) no 
plasmid; (lane 5) plasmid pATH2; or (lane 6) plasmid pATH-PHg. 
In all cases, strains were propagated under inducing conditions  as 
described in Materials  and Methods. The approximate  sizes of the 
truncated lacZ and trpE proteins encoded by the vectors and of the 
fusion proteins  are given in kD.  (B) Identification  of the CDC3 
product in blots of yeast proteins using affinity-purified antibodies. 
(Lanes 1-3) total cellular proteins were isolated from strain TD4 
containing (lane  1) plasmid  YEpl02 (ref.  25);  (lane  2) plasmid 
YEp-3PS1  (reference 25; Fig.  1 B); or (lane 3) plasmid YEpl02- 
(CDC3)2 (ref.  25; Fig.  1 A). Primary a~tibody used for all lanes 
was a 1:50 dilution of affinity-purified anti-trpE: CDC3. Secondary 
antibody used was a  1:100 dilution of HRP-conjngated goat anti- 
rabbit IgG. The position of the putative wild-type CDC3 protein at 
'~62 kD is indicated,  as is the truncated product (at '~50 kD) en- 
coded by plasmid YEp-3PS1.  The faint bands in lane 3 are pre- 
sumed  to  be  breakdown  products  of the  overproduced  62-kD 
protein. 
Kim et al. Localization of Yeast CDC3 C-ene Product  537 Figure 3. Immunofluorescence  localization of  the CDC3  and CDC12 gene products in wild-type and mutant cells. (,4 and I) C276 (wild-type) 
cells stained with anti-trpE:CDC3 antibodies  (A) or anfi-lacZ:CDC12 antibodies  (I). Individual cells are labeled  for reference in the text. 
(B and C) LH104-HO1  (cdc3) cells grown at 23°C (B) or at 36°C for 30 rain (C) and stained  with anti-trpE:CDC3 antibodies,  (D and 
E) LH17012-HO1 (cdclO) cells grown at '~23°C (D) or at 36°C for 30 rain (E) and stained with anti-trpE:CDC3 antibodies.  (Fand G) 
JPTA1493-HO1 (cdc12) cells grown at '~23°C (F) or at 36°C for 30 min (G) and stained  with anti-trpE:CDC3 antibodies.  (H) 314D5 
(cdc4) cells stained with anti-trpE:CDC3  antibodies after growth at 36°C for  4 h. (J-O) C276 cells double stained with antitubulin antibod- 
ies (J, L, and N) and either anti-trpE:CDC3 (K and O) or anfi-lacZ:CDC12 (M) antibodies.  Affinity-purified  rabbit anfi-trpE:CDC3 and 
anti-lacZ:CDC12 antibodies were used at 1:3 dilution;  FITC-conjugated goat anti-rabbit IgG secondary antibody was used at 1:40 dilution; 
rat antitubulin  antibody was used at 1:100 dilution,  and rhodamine-conjugated goat anti-rat IgG secondary antibody was used at 1:200 
dilution.  In the cells stained  with antitubulin  antibodies,  some fluorescence from the rhodamine label  is visible  when viewing for FITC 
fluorescence (K, M, and O). Cells  were photographed and printed at somewhat different  sizes to show optimum detail; magnifications 
are '~l,300-2,000-fold. 
directed the synthesis of a ,x,90-kD fusion protein (Fig. 2 A, 
lanes 4-6) when propagated under inducing conditions. 
Preparation of CDC3-specific Antibodies and 
Identification of the CDC3 Protein 
The lacZ: CDC3 and trpE: CDC3 fusion proteins were used 
to elicit antibody production and the resulting antisera were 
tested by immunoblotting for their ability to recognize pro- 
teins from the appropriate E. coli strains.  We obtained sera 
raised against each fusion protein that were able to recognize 
both fusion proteins in Western blots (data not shown; see 
similar experiments with anfisera raised against CDC12 fu- 
sion proteins in reference  10). Thus,  each serum appeared 
to contain antibodies  specific for CDC3 determinants  that 
are common to the two fusion proteins. 
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nitrocellulose-bound fusion proteins and the purified anti- 
bodies were used to identify the authentic CDC3 product in 
blots of yeast proteins. A "062-kD protein was recognized in 
blots of total protein from CDC3  +  cells containing no plas- 
mid (data not shown) or plasmid YEP102 (Fig. 2 B, lane/). 
A protein of the same mobility was present at higher levels 
in extracts of the same strain harboring a high-copy-number 
plasmid containing the entire CDC3 coding region (Fig. 2 
B, lane 3), indicating that the "062-kD protein is the authen- 
tic CDC3 gene product. In addition, a plasmid containing a 
tnmcated CDC3 coding region in the same strain directs the 
synthesis of a  "050-kD protein (Fig. 2 B, lane 2; see Dis- 
cussion). 
Immunofluorescence Localization of the CDC3 
Gene Product 
Use of affinity-purified anti-trpE:CDC3  (Fig. 3 A) or anti- 
lacZ:CDC3 (data not shown) antibodies to stain wild-type 
yeast cells revealed a localization pattern very similar to that 
seen for the CDCI2 gene product (10).  In cells with small 
buds, the CDC3 gene product appeared in a single or double 
ring at the base of the bud (Fig. 3 A, cells a-c). In cells with 
medium or large buds, the CDC3 gene product appeared as 
a pair of rings flanking the constriction of the mother-bud 
neck (Fig. 3 A, cells d-f). As noted previously (10), this ap- 
pearance is that expected for an antigen present in a struc- 
ture, such as the ring of 10-nm filaments, that follows the 
contour of the cell membrane through the neck region; thus, 
densest  packing  (in  a  two-dimensional projection),  and 
therefore brightest fluorescence, would occur on the slopes 
of the mother and bud portions of the cell flanking the neck 
constriction. Finally, many unbudded cells also appeared to 
possess rings of CDC3 antigen (Fig. 3 A, cells g-l), as con- 
sidered further below. 
Mutants defective in CDC3,  CDC]O, CDCll, or CDC12 
are unable to form or (at least for some alleles of CDCIO and 
CDC12) maintain rings of 10-nm filaments at restrictive tem- 
perature (Byers, B.,  and L.  Goetsch.  1976. J.  Cell Biol. 
70:35a;  1,  10).  The pattern of CDC3 product localization 
was examined in representative mutant strains. At permis- 
sive temperature, all four mutants displayed normal localiza- 
tion of the CDC3 product (Fig. 3, B, D, and F), although the 
staining was somewhat diminished in cdc3 (Fig. 3 B) and 
cddl  (strain JPT194-H01;  data not shown) cells. After 30 
rain at restrictive temperature (sufficient to cause disappear- 
ance of 10-nm filaments [1; Byers, B., and L. Goetsch. 1976. 
J.  Cell Biol.  70:35a] and delocalization of CDC12 product 
[10] in the cddO and cdcl2 cells), staining of CDC3 product 
was not detectable in cdc10 and cdcl2 cells (Fig. 3, E and 
G) and was greatly diminished or absent in cdc3 cells (Fig. 
3 C). cdcll cells showed only a minor reduction in staining 
intensity relative to the pattern observed at permissive tem- 
perature (data not shown). Moreover, a cdc4 mutant strain 
(which also forms multiple, abnormally elongated buds at 
restrictive temperature, but has normal rings of 10-nm illa- 
ments) displayed apparently normal localization of CDC3 
product to the mother-bud necks even after several hours at 
restrictive temperature (Fig. 3 H). Thus, the results obtained 
with the mutant strains are also consistent with the hypothe- 
sis that the CDC3 product is a constituent of the ring of 10- 
nm filaments. 
Electron microscopic observations have suggested that the 
ring of 10-nm filaments appears coincident with bud emer- 
gence and disappears just before cytokinesis (4, 5). To begin 
exploring the behavior of the filament-associated polypep- 
tides at the beginning and end of  the budding cycle, we exam- 
ined in detail the patterns of staining observed with CDC3- 
specific  and  CDC12-specific  antibodies  in exponentially 
growing wild-type cells. In a sample of strainC276, 62% of 
the cells were budded as judged by phase-contrast micros- 
copy. Immunofluorescence revealed detectable rings of the 
CDC3 and CDC12 antigens in 96 and 80% of the total popu- 
lation, respectively. When we attempted to score the unbud- 
ded cells alone, we detected rings of CDC3 and CDC12 prod- 
uct in 93  and 40%  of the ceils, respectively.- However,  it 
should be noted that the latter counts are somewhat uncertain 
because small buds are difficult to see under the conditions 
used for immunofluorescence; thus, cells with small buds 
may be inadvertantly included in the counts, with the effect 
of inflating the apparent proportions of unbudded cells that 
possess rings of CDC3 or CDC12 antigen. Nonetheless, it 
seems clear that both antigens (and especially the CDC3 
product) must (a) be organized into a ring structure before 
bud emergence; (b) linger in a ring structure after cytokine- 
sis; or (c) both. Support for possibility c is provided by the 
observation that the rings of antigen observed in unbudded 
cells appear to be of two types: first, a relatively narrow di- 
ameter, generally brightly staining structure (Fig. 3 A, cells 
g, h, and k [right-hand ring], and l [left-hand ring]; Fig. 3 
I, cells a and b), such as would be expected if the structures 
observed at the bases of small buds (Fig. 3 A, cells a-c; Fig. 
3, D and E of ref.  10) actually appeared in advance of bud 
emergence; and second, a relatively broad-diameter, gener- 
ally less brightly staining structure (Fig. 3 A, cells i, j, and 
k [left-hand ring], and I [fight-hand ring]; Fig. 3 I, cell c), 
such as would be expected if the structures of cells e and f, 
Fig. 3 A, were retained on mother and daughter cells after 
cytokinesis. The narrow and broad  rings were present in 
"035 and "058%, respectively, of the apparently unbudded 
cells stained with CDC3-specific  antibodies, and were each 
present in ,020% of the apparently unbudded cells stained 
with CDC12-specific antibodies. In addition, a small number 
of  apparently unbudded cell  s (and even some cells with small 
buds) displayed coincidentiy both a narrow ring and a broad 
ring when stained with CDC3-specific  antibodies (Fig. 3 A, 
ooIA 
o  ''-]'  -~ 2° R~  '° 
i  I  I 
0  30  60  90  120 
TIME (min) 
Figure  4.  T'Lming of  early 
events at the budding site in 
synchronized  cultures. Par- 
tiaily  synchronized budding 
was obtained (A) by isolating 
and culturing small unbudded 
cells of strain C276 or  (B) 
by  releasing cells  of strain 
CP1AB-1AA from alpha fac- 
tor arrest, as described in Ma- 
terials and Methods. Samples 
taken  at  appropriate times 
were examined for the pres- 
ence of buds (o), chitin rings 
(n),  rings  of CDC3 protein 
([]), and rings of CDC12 pro- 
tein (0). 
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c, above. However, cells with two rings were not observed 
after staining with CDC12-specific antibodies. 
Timing of  Early Events at the Budding  Site 
To examine more closely the timing of the appearance of the 
CDC3 and CDC12 proteins at the budding site, small unbud- 
ded cells were isolated and cultured in fresh mediuna.  The 
numbers of buds, chiti~ rings, and tings of CDC3 or CDC12 
•  %.5  -  ,  .  •  ~  • 
antagen  were  then  compared  during  the  partaally  syn- 
chronous round of budding that follo~;ved  (Fig. 4 A). Theini- 
ti~ ce'll population eQntained some cells with bud scars (i:e., 
chidfi tings from previous budding cycles) but few or none 
~vith'bfi~ls or with detectable tings of CDC3 or CD02 anti- 
gen..~us,  at each tiiiie point,  the total  number of chitin 
tings is somewhat greater than the number of newly formed 
chitin tings, whereas the buds and antigen tings observed are 
pFesumably all newly formed. With this in mind, Compari- 
son of the curves in Fig.  4 A suggests'that the CDC3 and 
CDC12 proteins localize to the budding site before bud eme  r- 
gence and apparently  also before chitin  ring formation. It 
shduld ~  noted, however, that immunofluorescende ~taining 
in the egrlier samples (up to 75 rain)  seemed suboptimal, 
pres0mably because of difficulties in permeabilizing  cells 
that were just emerging from stationary phase.  Therefore, 
the co.~nts of antigen rings in these early samples may have 
been distorted by a failure to detect some residual rings from 
earlier bl~dding  cycles, nascent tings from the new budding 
cycles,' or both. 
Because of this caveat, we also utilized a second method 
to  synchronize  budding.  MATa/MATa diploid  cells  Were 
treated with alpha factor to arrest the cells uniformly ~  the 
unbudded,  G1  phase  (33).  After  washing  ihe  cells  and 
resuspending  them in fresh medium,  the numbers of buds 
and tings of CDC3 or CDC12 antigen were determined a s a 
function of time.  (The formation of new chitin rings could 
not be followed in this experiment because of the many bud 
scars present in the initial population.) Fig. 4 B shows that 
the rings of CDC3 antigen appeared to form ,,o15 .min before 
bud emergence,  whereas  the rings  of CDC12 antigen  ap- 
peared to form approximately  coincident  with bud emer- 
gence. The apparent discrepancy between this and the other 
results on the timing of localization of the CDC12 product 
is considered in the Discussion. It should be noted that the 
alpha factor experiments are subject to the caveat that alpha 
factor itself may perturb the normal distribution or assembly 
of the CDC3 or CDC12 protein (see also below). 
Timing of  Late Events at the Budding Site 
We used three approaches to examine more closely the be- 
havior of the CDC3 and CDC12 polypeptides at the end of 
the budding cycle. In the first approach,  exponential-phase 
wild-type cells were examined by double-label immunofluo- 
rescence staining of tubulin and the CDC3 or CDC12 gene 
product.  Cells were classified according to the appearance 
of their mitotic spindles, and the presence or absence of de- 
tectable rings of CDC3 or CDC12 antigen at the neck:was 
noted.  Both proteins  appeared  to remain  localized to the 
neck region  so long  as  an  intact  spindle  was maintained 
(Fig. 3, J and K). As the spindle began to break down (late 
nuclear division),  the CDC12 protein seemed to disappear 
from the neck in most cells (Fig. 3, L and M). In contrast, 
the CDC3 protein seemed to be retained at the neck until 
very late stages, and probably until after nuclear division and 
cytokinesis were complete (Fig. 3, N and O). The results are 
summarized  in Table II..  " 
In the second approach, we asked whether detectabletings 
of CDC3 and CDC12 pr0te~.ins~remained.~at the necks of/vari- 
ous temperature-sensiti~e cell dix,  ision cycle mutants that.at= 
rest late in the budc~ing~  cyc!~ at restrictive: teml~rature (33). 
After 2-5 h at:restriofiv~ temperature, ~mutahtsarrested  in 
medial.nuclear division (cdc/3, cdcl6, and cdc17) or in late 
nuclear division (cdc14 and cdc15) appeared consistently to 
maintain  Structures  that  Contained  both  the  CDC3 and 
CDC12 proteins (Fig.  5, A-F; and data not shown). More- 
over, mutants arresting in very late nuclear division or be- 
tween  nuclear  division  and  cytokinesis  (cdc5 and  cdc18) 
also appeared to maintain the localization of the CDC3 and 
CDC12 proteins  (Fig.  5,  CRY),  although  the results with 
cdc5 were  somewhat heterogeneous.  When  strain  473D3 
(cdc5-1) was grown at restrictive temperature for 2 h,  by 
which time '~60% of the cells displayed large buds, detect- 
able rings of CDC3 and CDC12 antigens were present in 
nea~ly all cells.  Upon longer ~!ncubation at restrictive tem- 
perature, the population became very homogeneous (~95 % 
large-budded cells) as judged by phase-contrast microscopy, 
but the proportions  of cells displaying ~detectable  tings  of 
CD.C3 or CDC12 antigen declined.  By 5 h,  only ,,o67 and 
,y15% of the cells displayed detectable rings of the CDC3 
and CDC12 antigens; respectively. Consideration of the de- 
tailed time courses in these experiments  (not shown) indi- 
cated that most or all cells must have been arrested with large 
buds for >tl h before the antigen tings disappeared. In addi- 
tion, cells of strain JPT176-H01  (cdc5-2)  retained detect- 
able rings of both antigens on essentially all cells even after 
5 h at restrictive temperature (Fig. 5, I and M; and data not 
shown), although  staining  with  CDC12-specific antibodies 
was weal  Taken together,  these observations suggest that 
disassembly of the CDC3-containing and CDC12-containing 
structures is not specifically programmed in cells that have 
reached the cdc5 arrest point, and that the gradual disappear- 
ance of these structures in strain 473D3 (and of the CDC12- 
containing structures in strain JPT176-H01) reflects either a 
general cellular pathology or a slow leakage of the cells past 
the mutant block. The observation that tubulin immunofluo- 
rescence patterns also changed gradually in arrested 473D3 
cellsAs consistent with either of the latter interpretations. 
Table II. Localization of CDC3 and CDC12 Antigens in 
Wild-type Cells Late in the B,_:__rMing Cycle 
Cells with detectable rings of 
Spindle class*  CDC3 antigens  CDCI2 antigenS: 
%  % 
1  100  100 
II  100  60 
III  72  18 
* Mitotic spindle classes were defined as follows: (1) cells having long spin- 
dles showing no evidence of disassembly (see Fig. 3 J); (II) cells having spin- 
dles in early stages of disassembly (see Fig. 3 L); and (IIl) cells showing no 
remaining spindle, but apparently still  prior to cytokinesis (see Fig.  3 N). 
$ Percentages were based on counts of 50 cells for each sample. 
The Journal of Cell Biology, Volume 112,  1991  540 Figure 5. CDC3 and CDC12 protein localization in nuclear division mutants, alpha factor arrested cells (%hmoos"), and zygotes. Primary 
and secondary antibody concentrations were as described in the legend to Fig. 3. (A-N) Mutant ceils were double stained with antitubulin 
antibodies (B, D, F, H, J, L, and N) and with anti-trpE: CDC3 antibodies (,4, C, G, and l) or anti-lacZ: CDC12 antibodies (E, K, and M). 
Some fluorescence from the rhodamine (tubulin) label is visible when viewing for FITC (CDC3 or CDC12) fluorescence. (A and B) 281D5 
(cdcl6) cells after 7 h at 36°C. Similar results were obtained with strains 428D1  (cdcl3) and H178-1-1 (cdc17). (C and D) JPTI61-HO1 
(cdd5-28) cells after 3 h at 36°C. Similar results were obtained with strain 17017 (cddS-1). (E and F) JPT143-HO1  (cdd4-14) cells after 
4 b at 36°C. Similar results were obtained with strain 7041-HO1  (cdcl4-1).  (G, 1-1, K, and L) 14028-HO1  (cdc18) cells after 4 h at 36°C. 
(I, J, M, and N) JPT176-HO1  (cdc5-2) cells after 4 h (1 and J) or 3 h (M and N) at 36°C. (O and P) Shmoo cells of strain CP1AB-1AA 
after treatment with alpha factor for 160 rain, stained with anti-trpE: CDC3 antibodies (O) or Calcofluor (P). (Q and R ) Zygotes formed 
by mating strains C276-4A and C276-4B, stained with anti-trpE:CDC3 antibodies (Q) or Calcofluor (R). Cells are labeled for reference 
in the text. Cells were photographed and printed at somewhat different sizes to show optimum detail; magnifications are ,~l,300-2,000-fold. 
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the budding cycle involved treating an exponentially growing 
population of MATa/MATa cells with alpha factor to prevent 
new  budding  (and  thus,  presumably,  formation  of new 
budding-associated  rings of the CDC3 and CDC12 antigens), 
and following the disappearance of preexisting antigen rings 
as the cells completed division and arrested as unbudded 
cells.  Although  the results were somewhat variable (appar- 
ently due at least in part to variations  in the effectiveness of 
the  immunofluorescence  staining),  it  was  clear  that  the 
proportion of unbudded cells displaying rings of CDC3 anti- 
gen r~mained substantial  (10---40%) throughout the 100-120 
min in which new unbudded cells were being generated by 
cell division, and for '~20 min thereafter.  Thus,  the CDC3 
protein appeared to linger in a ring structure at the budding 
site for 920 min after cell division under these conditions. 
The  results  obtained with the  CDCl2-specific antibodies 
were similar, except that the proportions of unbudded cells 
displaying antigen rings were at all times smaller and more 
variable from experiment to experiment.  Thus, the ring of 
CDCI2 polypeptide appeared to linger atthe budding site for 
only a short time after cell division. 
Examination of CDC3 and CDC12 Proteins in 
Shmoos and Zygotes 
The association of the CDC3 and CDC12 proteins with the 
sites of cell wall reorganization  and chitin deposition in bud- 
cling cells suggested  that these proteins might  also be in- 
volved in the related  processes that occur in cells that are 
mating or responding  to mating pheromone (9, 26, 28, 36, 
41, 42, 43; S. Ford and J. Pringle,  manuscript in prepara- 
tion). Indeed, after several hours of  exposure to alpha factor, 
some shmoos (unbudded cells on which a broad protrusion 
has formed) exhibited faint but distinct bands of CDC3 and 
CDC12 immunottuorescence  around the protruding  regions 
(Fig. 5 O; and data not shown). This corresponded roughly 
with the regions  of chitin  deposition in these cells, as re- 
vealed by staining with Calcofluor (Fig. 5  P; reference 36). 
In mating  cells,  a faint band (or bands) of immunofluores- 
cence in the region of fusion was often detectable soon after 
fusion with CDC3-specific antibodies (Fig. 5 Q, ceils a and 
b and regions of cells d and e noted by arrowheads). Again, 
this  localization  corresponded roughly with the region of 
chitin deposition (Fig. 5 R). These immunofluorescence  pat- 
terns were not detectable in all shmoos and zygotes, and it 
was not always clear, that the structure stained was intracellu- 
lar (see the problems with cell wall staining artifacts in re~r- 
ence  10). Thus, we cannot be certain that the association of 
thf CDC3 ar~ CDC12 proteins with the regions of ceil wall 
re~t',ganizatiqn  is a normal feature of zygote and shmoo for- 
ma~t{on. It Was clear,  however, that as zygotes prepared to 
bud they formed rings of CDC3 protein (Fig. 5 Q, ceils c and 
d) and CDCI2 protein (not shown) that persisted as the buds 
emerged and enlarged  (Fig.  5 Q, cells e and f), essentially 
as seen in budding vegetative  cells. 
Discussion 
To study the intracellular  organization  and function of the 
yeast CDC3 product, we raised antibodies against the ~sion 
proteins encoded by in-frame fusions of CDC3 to the E. coli 
lacZ and trpE genes. Antisera raised against each fusion pro- 
rein were able to recognize both fusion proteins;  this both 
demonstrated the presence of CDC3-specific antibodies and 
/facilitated their effective affinity purification.  Immunoblot- 
ring experiments using the purified antibodies revealed a sin- 
gle polypeptide of ,,o62 kD in extracts  from normal yeast 
cells and a more abundant polypeptide of the same mobility 
in extracts from cells harboring a high-copy-number plasmid 
that contains the complete CDC3 coding region (11, 25). The 
size of the presumed CDC3 product agrees well with the 60 
kD predicted from the sequence (11). In addition,  the anti- 
bodies revealed an abundant polypeptide of ,v50 kD in ex- 
tracts from cells harboring a plasmid that appears to contain 
a CDC3 gone that is truncated at its 5' end (11). The size of 
this  polypeptide is consistent with the hypothesis  that its 
translation  begins at the first available ATG (codon 70 of the 
normal CDC3 coding region; reference 11). The retention of 
cdc3-complemenfing activity by this plasmid (25) suggests 
that the amino-terminal  segment of the CDC3 protein (a fea- 
ture not shared with the other known members of this gene 
family;  reference 11) is nonessential. 
In view of the similarities  in predicted amino  acid se- 
quence among the CDC3, CDCIO, CDC11, and CDC12 prod- 
ucts (11), it is noteworthy that the CDC3-specific antibodies, 
like the CDCl2-specific antibodies (10), showed no apparent 
cross-reaction with the other three gene products.  Althongh 
it is possible that further testing  may reveal  weak cross- 
reactions,  it seems likely that our immunofluorescence  ex- 
periments have indeed revealed the localization of the CDC3 
product and not of a weakly cross-reacting  species. As in 
previous studies (10, 23), affinity purification  of the CDC3- 
specific  antibodies  was  essential  to avoid misleading  im- 
munottuorescence  results due to other antibodies,  present in 
all rabbit sera tested, that were reactive with yeast cell con- 
stituents. 
The immunottuorescence  localization  of the CDC3 prod- 
uct in wild-type cells revealed patterns similar to those ob- 
served with CDC/2-specific (10) and CDC/0-specific  (H. B. 
Kim, S. Ketcham, and J. R. Pringle,  manuscript in prepara- 
tion)  antibodies.  These  staining  patterns  suggest  that  all 
three gene products are associated with the ring of 10-nm 
filaments in the mother-bud neck. This hypothesis  is sup- 
ported by the immunofluorescence  localization of  the CDC]2 
(10) and CDC3 products in mutant strains.  Localization of 
the CDC3 product to the neck region was lost rapidly after 
a shift to restrictive temperature in cddO or cdcl2 mutants, 
but not in cddl or cdc4 mutants,  consistent with electron 
microscopic observations  on the behavior of the 10-nm illa- 
ments in these strains  (1; Byers, B., and L. Goetsch.  1976. 
J. CellBiol. 70:35a; B. Byers and L. Goetsch, personal com- 
mmlication).  Results with the cdc3 mutant were more dif- 
ficult to interpret;  staining  of the neck region with CDC3- 
specific antibodies was lost rapidly after the shift to restric- 
tive temperature,  although the electron microscopic observa- 
tions suggest that the lO-nm filaments should remain in place 
until completion of the cell cycle in progress at the time of 
the temperature shift. Presumably,  either the mutant CDC3 
product remains in the filaments but becomes unreactive  to 
the antibodies  after the temperature shift,  or it dissociates 
from the  filaments  without destroying  their  higher-order 
structure. 
The most economical interpretation  of the available data 
is that the CDC3, CDCIO, CDCI1, and CDC12 gene products 
are the primary constituents  of the lO-nm filaments. As the 
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no extensive similarities to those of other known filament- 
forming proteins (11), the yeast 10-urn filaments would thus 
represent a novel type of eukaryotic cytoskeletal element. 
However,  it also remains possible that the CDC3,  CDCIO, 
CDCll, and CDC12 products are all accessory proteins that 
associate with a filamentous structure composed primarily 
of some as yet unidentified, but more conventional, filament- 
forming protein. 
Electron microscopic observations have suggested that the 
10-nm filaments assemble at the budding site coincident with 
early bud emergence and disassemble rather abruptly just 
before cytokinesis (4,  5). We attempted to explore further 
the assembly and disassembly processes using the CDC3- 
specific and  CDC12-specific  antibodies.  Interpretation of 
our results is subject to three major caveats.  First, as noted 
above, we do not know the degree to which either protein is 
responsible for the higher-order structure of the filaments as 
observed in the electron microscope. Thus, the presence of 
the CDC3 and CDC12 products at a given site may not neces- 
sarily imply the presence of filaments at that site, and vice 
versa. Second, the electron microscopic studies themselves 
suffer from the uncertainty that the filaments can be difficult 
to  see  even  in budded cells,  and  would have been  very 
difficult  to see in unbudded cells (B. Byers, personal commu- 
nication). Thus, it is possible that the filaments are actually 
assembled before bud emergence, or remain assembled at 
the budding site after cytokinesis, at least in some cells. 
Third, apparent differences in the behavior of the CDC3 and 
CDC12 polypeptides might reflect instead differences in the 
affinities of the respective antibodies. 
With these caveats in mind, the following comments can 
be  made.  First,  immunofluorescence observations  using 
wild-type,  nuclear division-mutant,, and oL-factor-arrested 
cells consistently indicated that the CDC3 product remains 
localized to a ring structure at the old budding site on both 
mother  and  daughter  cells  after  cytokinesis.  The  corre- 
sponding observations with respect to the CDC12 product 
were less consistent (perhaps reflecting the variable efficacy 
of the immunofluorescence staining), but in aggregate sug- 
gest that this polypeptide may behave similarly. It appears 
that  the  CDC3 and  CDC12  antigen rings  then disappear 
gradually during the subsequent unbudded phase, at rates 
that may differ for CDC3 and CDC12, and that may also vary 
from ceil to cell. If we take the electron microscopic obser- 
vations at face value, our results thus suggest that the higher- 
order  structure  of the  filaments may disassemble before 
cytokinesis  even  though  at  least  some  of the  filament- 
associated polypeptides remain localized to the region where 
the filaments had been. If there is a specific point in the cell 
cycle at which filament disassembly is triggered, it is appar- 
ently not reached in any of the mutants blocked in medial or 
late  stages  of nuclear  division,  as  electron  microscopic 
(Byers, B., and L. Goetsch.  1976. J.  Cell BioL  70:35a; B. 
Byers, personal communication) and immunofluorescence 
observations are consistent in indicating that filaments and 
filament-associated polypeptides  remain  in  place  at  the 
mother-bud neck in arrested cells of these mutants. Cells 
blocked in nuclear division by the microtubule-disassembling 
drug nocodazole also retain 10-nm filaments at the mother- 
bud neck for extended periods, as judged by EM (19). 
Second,  immunofluoreseence observations on exponen- 
tially growing and synchronized cultures consistently indi- 
cated that the CDC3 product is localized to a ring structure 
at the presumptive budding site well before chitin-ring for- 
marion and the formation of  buds visible by light microscopy 
(1>15 rain under the growth conditions used).  The corre- 
sponding observations for CDC12 were again less consistent, 
but in aggregate suggest that this polypeptide also may be 
localized to the budding site at least a few minutes before bud 
emergence. If we take the electron microscopic observations 
at face value (but note the caveat above), our results thus sug- 
gest that the higher-order structure of the filaments may as- 
sembly only some time after the known filament-associated 
polypeptides have been localized to the budding site. 
In any case, the immunofluorescence observations appear 
to clarify the possible role of the 10-nm filaments in forma- 
tion of the chitin ring. Such a role had been suggested by the 
evidence that the cdc3,  cdclO, cdcll,  and cdc12 mutants, 
which lack the 10-nm filaments, also fail to form normal chi- 
tin rings, whereas other cdc mutants such as cdc4,  which 
possess  apparently  normal  10-nm  filaments,  also  form 
normal-looking chitin rings (Fig. 3, C, E, G, and H; Byers, 
B., and L. Goetsch. 1976. J.  Cell Biol.  70:35a; references 
l, 10; B. Byers, personal communication). This correlation 
might mean either that chitin-ring formation is dependent on 
the 10-urn filaments or the reverse, but support for the former 
interpretation was provided by the observations (a) that the 
CDC3, CDCIO, and CDCI2 gene products all localize to the 
vicinity of the 10-nm filaments; and (b) that the cdclO and 
cdc12 mutants lose preexisting filaments after a shift to re- 
strictive  temperature;  taken together,  these  data  suggest 
strongly that the primary lesions in these mutants involve 
formation of the 10-nm filaments. Moreover, a chsl::URA3 
csd2-1 mutant strain (3;  C. Bulawa, personal communica- 
tion), which produces little or no chitin, nonetheless shows 
apparently normal localization of the CDC3,  CDCIO, and 
CDC12 products (our unpublished results), suggesting that 
filament formation is not dependent on the presence of a chi- 
tin ring. However the putative role for the 10-nm filaments 
in formation of the chitin ring was difficult to reconcile with 
the electron microscopic evidence that the filaments only 
form as the bud is emerging (5), whereas the chitin ring is 
well developed by that time (Fig. 4 A; references 16, 21). 
From our immunofluorescence studies, it now seems clear 
that at least some of the filament-associated polypeptides, if 
not actually the filaments themselves, are assembled at the 
budding site in time to play a role in chitin ring formation. 
However,  it should also be noted that the 10-urn filaments 
and their associated polypeptides cannot be the only factors 
determining where chitin is deposited, as these elements ap- 
pear equilaterally on both sides of the neck, whereas chitin 
is deposited only in the wall of the mother cell. A further 
consideration is the formation of septum-like structures at 
aberrant locations in cdc3, cddO, cdc11, and cdc12 mutants 
(38);  one  interpretation of these  observations is  that the 
10-nm filaments are necessary for the normal positioning of 
the chitin ring, but not actually for its formation. 
An approximate correlation between the distribution of  the 
CDC3 and CDC12 products and the sites of cell wall reor- 
ganization and chitin deposition was also observed (with 
some significant uncertainties; see Results) in shmoos and 
zygotes. It is not clear whether the apparently diffuse local- 
ization of the CDC3 and CDC12 polypeptides in these ceils 
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responding regions, or whether these polypeptides can func- 
tion without forming filaments. 
The observation that the CDC3 polypeptide, at least, ap- 
pears at the presumptive budding site well in advance of bud 
emergence raises the very interesting questions of whether 
it is the 10-urn-filament-associated polypeptides or the actin 
network (2, 21, 30) that assembles first at the budding site, 
and of whether the later of these events is dependent upon 
the earlier. It should be noted that reorganizations of the actin 
network and of the 10-nm-filament-associated polypeptides 
are also temporally correlated at the end of the budding cycle 
(see above and refs.  2, 21, 30) and in shmoos and zygotes 
(see above;  ref.  15; and S. Ford and J. Pringle, manuscript 
in preparation).  We are currently  investigating  these issues. 
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